Home / Inspections / 1255733

FDA Inspection 1255733 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1035346

The FDA completed an inspection of Octapharma Plasma, Inc. on November 21, 2024 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 21, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Jacksonville, FL (United States)

Facility

Other inspections at this facility

  • 1090929 (NAI Wed Apr 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004544 (VAI Thu Jan 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 902074 (NAI Wed Oct 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 792075 (NAI Thu Jul 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 767449 (NAI Thu Feb 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources